Axewik Technologies
visit site- $10,000+
- 10 - 49 employees
- Surat, India
Client Insights
Industry Expertise
70%
20%
10%
Client Size Distribution
Small Business (<$10M) 90%
Midmarket ($10M - $1B) 10%
Common Project Size
$10K-$49K 1 project
Clients
This provider has not added their key clients.
Highlights from Recent Projects
Axewik Technologies successfully completed a mobile application development project for Kegel 360, a health and wellness company. The main deliverables involved the design, development, testing, and launch of a women's wellness Android application called Cycle Yoga – Period Tracker. This app combined menstrual cycle tracking with guided yoga and pelvic floor fitness. Core features included intuitive cycle tracking, calendar-based visualization of cycle history, and wellness tracking for symptoms, moods, and personal health notes. Axewik was chosen for this project due to their high ratings, budget-friendly pricing, and proficiency in custom development.
The team at Axewik further enriched the application with a premium yoga library focused on wellness and pelvic floor health. They ensured the security of user authentication and account management and seamlessly configured in-app purchases and subscription management for premium content. Moreover, they performed quality assurance testing, resolved bugs, and executed compatibility testing across supported Android devices. Axewik's technical prowess extended to preparing the app's assets for the Google Play Store and managing its release.
The outcome of the project proved exceedingly satisfactory. Axewik Technologies demonstrated their comprehensive understanding of the software development lifecycle, delivering a high-quality application that provides users with an intuitive platform to manage menstrual cycles, track wellness data, and access guided yoga content. The application, published under the name Kegel 360 on Google Play, has been widely recognised for its seamless interface, robust functionalities, and privacy-focused mobile experience.